• Immunotherapy for Early-Stage Resectable NSCLC: Optimizing Multidisciplinary Management Today

  • Jul 17 2024
  • Length: 30 mins
  • Podcast

Immunotherapy for Early-Stage Resectable NSCLC: Optimizing Multidisciplinary Management Today By cover art

Immunotherapy for Early-Stage Resectable NSCLC: Optimizing Multidisciplinary Management Today

Listen for free

View show details

  • Summary

  • Clinical trials have reshaped multidisciplinary treatment paradigms for early-stage disease. Is your clinic up to date?

    Credit available for this activity expires: 7/15/25
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001332?ecd=bdc_podcast_libsyn_mscpedu
    Show more Show less
activate_primeday_promo_in_buybox_DT
Physical Illness & Disease Hygiene & Healthy Living
Show more Show less

What listeners say about Immunotherapy for Early-Stage Resectable NSCLC: Optimizing Multidisciplinary Management Today

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available